(Q33341069)

English

Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Helena Mertlíková-Kaiserová

4

object named as

H Kaiserová

0 references

object named as

O Popelová

3

0 references

object named as

M Hroch

6

0 references

author name string

T Simůnek

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

M Sterba

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

H Kaiserová

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

M Adamcová

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

P Hasková

7

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

P Ponka

8

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

V Gersl

9

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

language of work or name

0 references

publication date

9 June 2008

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

British Journal of Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

155

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

138-148

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Tuning cell cycle regulation with an iron key.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

21 June 2018

New iron chelators in anthracycline-induced cardiotoxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

21 June 2018

Dexrazoxane: how it works in cardiac and tumor cells. Is it a prodrug or is it a drug?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

21 June 2018

Molecular and cellular mechanisms of anthracycline cardiotoxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

21 June 2018

Role of mtDNA lesions in anthracycline cardiotoxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

21 June 2018

Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

21 June 2018

Anthracycline cardiotoxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

21 June 2018

Iron is not involved in oxidative stress-mediated cytotoxicity of doxorubicin and bleomycin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

21 June 2018

Adriamycin-induced oxidative mitochondrial cardiotoxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

21 June 2018

Cardioprotective effects of a novel iron chelator, pyridoxal 2-chlorobenzoyl hydrazone, in the rabbit model of daunorubicin-induced cardiotoxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

21 June 2018

Adriamycin-induced oxidative stress, activation of MAP kinases and apoptosis in isolated cardiomyocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

21 June 2018

The evolution of iron chelators for the treatment of iron overload disease and cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

21 June 2018

Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

21 June 2018

SIH--a novel lipophilic iron chelator--protects H9c2 cardiomyoblasts from oxidative stress-induced mitochondrial injury and cell death.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

21 June 2018

Pathophysiology of anthracycline- and radiation-associated cardiomyopathies: implications for screening and prevention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

21 June 2018

Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

21 June 2018

Structure, function, and mechanism of ribonucleotide reductases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

21 June 2018

Doxorubicin cardiotoxicity and the control of iron metabolism: quinone-dependent and independent mechanisms.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

21 June 2018

The current and future role of dexrazoxane as a cardioprotectant in anthracycline treatment: expert panel review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

21 June 2018

Pyridoxal isonicotinoyl hydrazone and its analogues.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

21 June 2018

The labile iron pool: characterization, measurement, and participation in cellular processes(1).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

21 June 2018

Transferrin receptor-dependent iron uptake is responsible for doxorubicin-mediated apoptosis in endothelial cells: role of oxidant-induced iron signaling in apoptosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

21 June 2018

Chemical, biological and clinical aspects of dexrazoxane and other bisdioxopiperazines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

21 June 2018

Visualization of doxorubicin-induced oxidative stress in isolated cardiac myocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

21 June 2018

The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

21 June 2018

A randomized controlled trial assessing the prevention of doxorubicin cardiomyopathy by N-acetylcysteine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

21 June 2018

Intralysosomal iron chelation protects against oxidative stress-induced cellular damage.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

31 October 2018

Dietary vitamin E decreases doxorubicin-induced oxidative stress without preventing mitochondrial dysfunction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

31 October 2018

Study of daunorubicin cardiotoxicity prevention with pyridoxal isonicotinoyl hydrazone in rabbits.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

31 October 2018

Chromatographic methods for the separation of biocompatible iron chelators from their synthetic precursors and iron chelates.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

31 October 2018

Deferoxamine induces prolonged cardiac preconditioning via accumulation of oxygen radicals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

31 October 2018

A study of potential toxic effects after repeated 10-week administration of a new iron chelator--salicylaldehyde isonicotinoyl hydrazone (SIH) to rabbits.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

31 October 2018

Oxidative stress mediates toxicity of pyridoxal isonicotinoyl hydrazone analogs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

31 October 2018

The oral iron chelator ICL670A (deferasirox) does not protect myocytes against doxorubicin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

31 October 2018

Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

31 October 2018

Anthracyclines induce accumulation of iron in ferritin in myocardial and neoplastic cells: inhibition of the ferritin iron mobilization pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

31 October 2018

Deferiprone protects against doxorubicin-induced myocyte cytotoxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

31 October 2018

Doxorubicin irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: evidence for distinct metabolic pathways and implications for iron-mediated cardiotoxicity of antitumor therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

31 October 2018

Doxorubicin-induced persistent oxidative stress to cardiac myocytes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

31 October 2018

The antioxidant effects of a novel iron chelator salicylaldehyde isonicotinoyl hydrazone in the prevention of H(2)O(2) injury in adult cardiomyocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527851

31 October 2018

Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: A study of salicylaldehyde isonicotinoyl hydrazone (SIH)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18536744

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topoisomerase IIbeta mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane

1 reference

https://pubmed.ncbi.nlm.nih.gov/18536744

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potentiation of Doxorubicin cardiotoxicity by iron loading in a rodent model

1 reference

https://pubmed.ncbi.nlm.nih.gov/18536744

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anthracycline toxicity is potentiated by iron and inhibited by deferoxamine: studies in rat heart cells in culture

1 reference

https://pubmed.ncbi.nlm.nih.gov/18536744

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxidative destruction of erythrocyte ghost membranes catalyzed by the doxorubicin-iron complex

1 reference

https://pubmed.ncbi.nlm.nih.gov/18536744

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of iron in the potentiation of anthracycline cardiotoxicity: identification of heart cell mitochondria as a major site of iron-anthracycline interaction

1 reference

https://pubmed.ncbi.nlm.nih.gov/18536744

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of free and bound malondialdehyde in plasma by high-performance liquid chromatography as the 2,4-dinitrophenylhydrazine derivative

1 reference

https://pubmed.ncbi.nlm.nih.gov/18536744

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of different iron chelators as protective agents against acute doxorubicin-induced cardiotoxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/18536744

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relationship of intracellular iron chelation to the inhibition and regeneration of human ribonucleotide reductase

1 reference

https://pubmed.ncbi.nlm.nih.gov/18536744

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topoisomerase II Mediated DNA Double-Strand Breaks: Implications in Doxorubicin Cardiotoxicity and Prevention by Dexrazoxane

1 reference

https://api.crossref.org/works/10.1038%2FBJP.2008.236

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/BJP.2008.236

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33341069&oldid=1536773393"